Antibody response to pneumococcal vaccination as a function of preimmunization titer.
about
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsImpact of analytical variability on clinical interpretation of multiplex pneumococcal serology assaysMultilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurementsFifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide ResponseAdvances in basic and clinical immunology in 2009The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency.Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitisDNA vaccines for targeting bacterial infections.New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures.Detection of antibody responses against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis proteins in children with community-acquired pneumonia: effects of combining pneumococcal antigens, pre-existing antibody levels, samA randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus.Measurement of Typhim Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency.Immunogenicity of pneumococcal polysaccharide vaccine in adult systemic lupus erythematosus patients undergoing immunosuppressive treatment.Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.
P2860
Q28240370-D1661245-A57D-4FEA-8010-D298B04B2A06Q28384900-8D8D3262-5E81-4221-B715-3F0CDBC6BEE5Q28390191-3CC47467-E077-4798-87FF-18E3DDD2CE15Q33665323-EBF4AA98-0644-4103-A989-1661BFE5BC59Q33737600-5006DD03-15BF-4F40-8285-A22FD5DF13EEQ33840276-9A1C856D-713D-4DC3-B591-C93871499CE0Q35868890-25FFDA42-D32E-4FBF-B9CA-BCDCD7C7A507Q36070723-6AB0B362-5F6E-4CC5-9741-3BA48B2803FAQ37771943-3FDA6741-B547-4FBE-9849-DF8D256C9A6CQ38121956-A7E0E0A3-E0B8-419E-9126-A7CAF19C48C1Q38152821-8510B311-FAE7-484C-9FBA-ED8889C72C2DQ41305837-D73CA5C4-CE6C-42D3-BB46-98DC6CC69497Q47116737-BE3E2E6B-8A7E-46F9-82D6-73842132D8BEQ48152472-34B0948C-318F-43E9-A590-C6685CA5CE6EQ54438627-59B3F365-1B55-4EFF-8840-C93E9845DB4AQ55186159-E647A704-7F90-4864-B3B4-E0853C5356EC
P2860
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@ast
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@en
type
label
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@ast
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@en
prefLabel
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@ast
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@en
P2093
P2860
P1476
Antibody response to pneumococcal vaccination as a function of preimmunization titer.
@en
P2093
Brian J Smith
Nathaniel D Hare
Zuhair K Ballas
P2860
P304
P356
10.1016/J.JACI.2008.09.021
P407
P577
2008-10-25T00:00:00Z